Research Article
Epidemiologic Characteristics of Adolescents with COVID-19 Disease with Acute Hypoxemic Respiratory Failure
Table 2
Selected treatment and outcome characteristics of hospitalized patients.
| Characteristics | Total (n = 47) |
| COVID-19 therapy | Hydroxychloroquine, n (%) | 8 (17%) | Azithromycin, n (%) | 3 (6.4%) | Remdesivir, n (%) | 5 (10.6%) | Corticosteroid, n (%) | 26 (55.3%) | IL-6 inhibitor, n (%) | 1 (2.1%) |
| Complications | ARDS, n (%) | 4 (8.5%) | AKI n (%) | 2 (4.2%) |
| Anoxic cerebral encephalopathy | 1 (2.1%) |
| Outcomes | Status on hospital day 14, n (%) | Discharged (%) | 42 (89%) | Mortality, n (%) | 0 (0%) |
|
|